RAB9AP4

Across TCGA pan-cancer cohorts, RAB9AP4 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RAB9AP4 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RAB9AP4 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RAB9AP4 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA, THCA, and KIRC are the cancer types where RAB9AP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	II,III,IV	0.850	0.263	.001	60	view →
THCA	OS	Tertile	All	0.964	0.993	.005	39	view →
KIRC	DFS	Tertile	II,III,IV	0.100	0.761	<.001	36	view →
HNSC	DFS	Tertile	All	0.170	0.627	.017	36	view →
LUSC	OS	Tertile	II,III,IV	0.043	0.781	<.001	36	view →
SKCM	OS	Tertile	III,IV	0.268	0.710	<.001	27	view →
TGCT	DFS	Tertile	All	0.082	0.837	<.001	18	view →
COAD	OS	Tertile	II,III,IV	0.117	0.788	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RAB9AP4–ESCA (DFS)

Open the ESCA breakdown →